Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

A 70-Year Old Man with Dystonic and Choreiform Movements.

Perez A, Roman GC, Powell SZ, Fisher R, Rivera AL, Masdeu JC, Cykowski MD.

Brain Pathol. 2020 Mar;30(2):415-416. doi: 10.1111/bpa.12819. No abstract available.

PMID:
32100432
2.

Anatomy of 18F-GE180, a failed radioligand for the TSPO protein.

Zanotti-Fregonara P, Pascual B, Rostomily RC, Rizzo G, Veronese M, Masdeu JC, Turkheimer F.

Eur J Nucl Med Mol Imaging. 2020 Feb 22. doi: 10.1007/s00259-020-04732-y. [Epub ahead of print] No abstract available.

PMID:
32088848
3.

Longitudinal Positron Emission Tomography of Dopamine Synthesis in Subjects with GBA1 Mutations.

Lopez G, Eisenberg DP, Gregory MD, Ianni AM, Grogans SE, Masdeu JC, Kim J, Groden C, Sidransky E, Berman KF.

Ann Neurol. 2020 Apr;87(4):652-657. doi: 10.1002/ana.25692. Epub 2020 Feb 22.

PMID:
32030791
4.

Posterior primary progressive prosopagnosia: Structural and molecular imaging.

Pascual B, Masdeu JC, Funk Q, Zanotti-Fregonara P, Shyer M, Rockers E, Schulz PE.

Neurology. 2020 Feb 25;94(8):360-361. doi: 10.1212/WNL.0000000000009001. Epub 2020 Jan 21. No abstract available.

PMID:
31964687
5.

Neuroimaging of Diseases Causing Dementia.

Masdeu JC.

Neurol Clin. 2020 Feb;38(1):65-94. doi: 10.1016/j.ncl.2019.08.003. Epub 2019 Nov 7. Review.

PMID:
31761062
6.

Medicare for All?

Masdeu JC.

Ann Neurol. 2020 Jan;87(1):155-156. doi: 10.1002/ana.25631. Epub 2019 Nov 6. No abstract available.

PMID:
31658384
7.

Letter to the Editor re: Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Zanotti-Fregonara P, Veronese M, Rizzo G, Pascual B, Masdeu JC, Turkheimer FE.

Mol Imaging Biol. 2020 Feb;22(1):10-12. doi: 10.1007/s11307-019-01433-3. No abstract available.

PMID:
31641965
8.

End of life: Expert care and support, not physician-hastened death.

Masdeu JC, Aksamit AJ, Carver AC, Foley KM, Kass JS, Martin RA, McCusker EA, McQuillen MP, Mehanna R, Payne R, Victor SJ, Warach S.

Neurology. 2019 Oct 22;93(17):729-734. doi: 10.1212/WNL.0000000000008356. Epub 2019 Sep 17.

9.

Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network.

Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu M, Spann B, Román GC, Schulz PE, Karmonik C, Appel SH, Masdeu JC.

J Nucl Med. 2020 Feb;61(2):263-269. doi: 10.2967/jnumed.118.225508. Epub 2019 Jul 26.

PMID:
31350322
10.

Head-to-head comparison of 11C-PBR28 and 11C-ER176 for quantification of the translocator protein in the human brain.

Zanotti-Fregonara P, Pascual B, Veronese M, Yu M, Beers D, Appel SH, Masdeu JC.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1822-1829. doi: 10.1007/s00259-019-04349-w. Epub 2019 May 31.

PMID:
31152207
11.

Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging.

Johnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJ.

Neurology. 2019 Jan 22;92(4):199-203. doi: 10.1212/WNL.0000000000006812.

12.

The validity of 18F-GE180 as a TSPO imaging agent.

Zanotti-Fregonara P, Veronese M, Pascual B, Rostomily RC, Turkheimer F, Masdeu JC.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1205-1207. doi: 10.1007/s00259-019-4268-4. Epub 2019 Jan 17. No abstract available.

PMID:
30656358
13.

"Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia.

Pascual B, de Bot ST, Daniels MR, França MC Jr, Toro C, Riverol M, Hedera P, Bassi MT, Bresolin N, van de Warrenburg BP, Kremer B, Nicolai J, Charles P, Xu J, Singh S, Patronas NJ, Fung SH, Gregory MD, Masdeu JC.

AJNR Am J Neuroradiol. 2019 Jan;40(1):199-203. doi: 10.3174/ajnr.A5935. Epub 2019 Jan 3.

14.

Functional alterations of myeloid cells during the course of Alzheimer's disease.

Thome AD, Faridar A, Beers DR, Thonhoff JR, Zhao W, Wen S, Pascual B, Masdeu JC, Appel SH.

Mol Neurodegener. 2018 Nov 13;13(1):61. doi: 10.1186/s13024-018-0293-1.

15.

Clinical Findings in a Multicenter MRI Study of Mild TBI.

Shetty T, Nguyen JT, Cogsil T, Tsiouris AJ, Niogi SN, Kim EU, Dalal A, Halvorsen K, Cummings K, Zhang T, Masdeu JC, Mukherjee P, Marinelli L.

Front Neurol. 2018 Oct 23;9:836. doi: 10.3389/fneur.2018.00836. eCollection 2018.

16.

Reader response: The neurologic exam: Is it extinct?

Masdeu JC.

Neurology. 2018 Aug 14;91(7):333. doi: 10.1212/WNL.0000000000005990. No abstract available.

PMID:
30104232
17.

Longitudinal Resting State Functional Connectivity Predicts Clinical Outcome in Mild Traumatic Brain Injury.

Madhavan R, Joel SE, Mullick R, Cogsil T, Niogi SN, Tsiouris AJ, Mukherjee P, Masdeu JC, Marinelli L, Shetty T.

J Neurotrauma. 2019 Mar 1;36(5):650-660. doi: 10.1089/neu.2018.5739. Epub 2018 Oct 3.

PMID:
30024343
18.

Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain.

Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, Carter R, Appel SH, Atassi N, Masdeu JC.

J Nucl Med. 2018 Aug;59(8):1260-1266. doi: 10.2967/jnumed.117.203109. Epub 2018 Jan 18.

19.

A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer's Disease in Clinical Trials.

Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK; Alzheimer's Disease Neuroimaging Initiative.

Curr Alzheimer Res. 2018 Mar 14;15(5):429-442. doi: 10.2174/1567205014666171106150309.

PMID:
29110613
20.

Letter re: High hypothetical interest in physician-assisted death in multiple sclerosis.

Masdeu JC.

Neurology. 2017 Sep 26;89(13):1428. doi: 10.1212/WNL.0000000000004431. No abstract available.

PMID:
28947581
21.

BDNF Val66Met polymorphism tunes frontolimbic circuitry during affective contextual learning.

Jabbi M, Cropp B, Nash T, Kohn P, Kippenhan JS, Masdeu JC, Mattay R, Kolachana B, Berman KF.

Neuroimage. 2017 Nov 15;162:373-383. doi: 10.1016/j.neuroimage.2017.08.080. Epub 2017 Sep 1.

22.

Tau and Cortical Thickness in Alzheimer Disease.

Masdeu JC.

JAMA Neurol. 2017 Apr 1;74(4):390-392. doi: 10.1001/jamaneurol.2016.5701. No abstract available.

PMID:
28241165
23.

Detecting synaptic autoantibodies in psychoses: need for more sensitive methods.

Masdeu JC.

Curr Opin Neurol. 2017 Jun;30(3):317-326. doi: 10.1097/WCO.0000000000000447. Review.

PMID:
28234799
24.

Future Directions in Imaging Neurodegeneration.

Masdeu JC.

Curr Neurol Neurosci Rep. 2017 Jan;17(1):9. doi: 10.1007/s11910-017-0718-1. Review.

PMID:
28210978
25.

Preface.

Masdeu JC, González RG.

Handb Clin Neurol. 2016;135:ix. doi: 10.1016/B978-0-444-53485-9.09988-8. No abstract available.

PMID:
27432688
26.

Inherited or acquired metabolic disorders.

Eichler F, Ratai E, Carroll JJ, Masdeu JC.

Handb Clin Neurol. 2016;135:603-636. doi: 10.1016/B978-0-444-53485-9.00029-5. Review.

PMID:
27432685
27.

Genetic and degenerative disorders primarily causing dementia.

Masdeu JC, Pascual B.

Handb Clin Neurol. 2016;135:525-564. doi: 10.1016/B978-0-444-53485-9.00026-X. Review.

PMID:
27432682
28.

Preface.

Masdeu JC, González RG.

Handb Clin Neurol. 2016;136:ix. doi: 10.1016/B978-0-444-53486-6.09986-5. No abstract available.

PMID:
27430473
29.

Brain CT and MRI: differential diagnosis of imaging findings.

Masdeu JC, Gadhia R, Faridar A.

Handb Clin Neurol. 2016;136:1037-54. doi: 10.1016/B978-0-444-53486-6.00054-5. Review.

PMID:
27430457
30.

Gait and balance disorders.

Masdeu JC.

Handb Clin Neurol. 2016;136:939-55. doi: 10.1016/B978-0-444-53486-6.00048-X. Review.

PMID:
27430451
31.

NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?

Masdeu JC, Dalmau J, Berman KF.

Trends Neurosci. 2016 May;39(5):300-310. doi: 10.1016/j.tins.2016.02.006. Epub 2016 Apr 26. Review.

32.

Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo.

Eisenberg DP, Kohn PD, Hegarty CE, Ianni AM, Kolachana B, Gregory MD, Masdeu JC, Berman KF.

Neuropsychopharmacology. 2016 Aug;41(9):2303-8. doi: 10.1038/npp.2016.31. Epub 2016 Feb 29.

33.

Tau, amyloid, and hypometabolism in the logopenic variant of primary progressive aphasia.

Pascual B, Masdeu JC.

Neurology. 2016 Feb 2;86(5):487-8. doi: 10.1212/WNL.0000000000002340. No abstract available.

PMID:
26833938
34.

New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.

Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2015 Nov 12;7(1):64. doi: 10.1186/s13195-015-0151-0.

35.

In Memoriam: Frank A. Rubino, MD.

Freeman WD, Brazis PW, Biller J, Masdeu JC, Merrilees GR, Olson S.

JAMA Neurol. 2015 Nov;72(11):1384-5. doi: 10.1001/jamaneurol.2015.2308. No abstract available.

PMID:
26551966
36.

Advanced Neuroimaging Methods Towards Characterization of Early Stages of Alzheimer's Disease.

Sepulcre J, Masdeu JC.

Methods Mol Biol. 2016;1303:509-19. doi: 10.1007/978-1-4939-2627-5_31. Review.

PMID:
26235088
37.

Large-scale brain networks of the human left temporal pole: a functional connectivity MRI study.

Pascual B, Masdeu JC, Hollenbeck M, Makris N, Insausti R, Ding SL, Dickerson BC.

Cereb Cortex. 2015 Mar;25(3):680-702. doi: 10.1093/cercor/bht260. Epub 2013 Sep 24.

38.

Intracranial arteries in individuals with the elastin gene hemideletion of Williams syndrome.

Wint DP, Butman JA, Masdeu JC, Meyer-Lindenberg A, Mervis CB, Sarpal D, Morris CA, Berman KF.

AJNR Am J Neuroradiol. 2014 Jan;35(1):90-4. doi: 10.3174/ajnr.A3641. Epub 2013 Jul 18.

39.

Searching for novelty: challenges with open access data.

Masdeu JC.

Ann Neurol. 2012 Dec;72(6):983. doi: 10.1002/ana.23755. No abstract available.

PMID:
23280847
40.

Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.

Masdeu JC, González-Pinto A, Matute C, Ruiz De Azúa S, Palomino A, De Leon J, Berman KF, Dalmau J.

Am J Psychiatry. 2012 Oct;169(10):1120-1. doi: 10.1176/appi.ajp.2012.12050646. No abstract available.

41.

Decreased carbon-11-flumazenil binding in early Alzheimer's disease.

Pascual B, Prieto E, Arbizu J, Marti-Climent JM, Peñuelas I, Quincoces G, Zarauza R, Pappatà S, Masdeu JC.

Brain. 2012 Sep;135(Pt 9):2817-25. doi: 10.1093/brain/aws210.

PMID:
22961552
42.

Interactive effect of apolipoprotein e genotype and age on hippocampal activation during memory processing in healthy adults.

Nichols LM, Masdeu JC, Mattay VS, Kohn P, Emery M, Sambataro F, Kolachana B, Elvevåg B, Kippenhan S, Weinberger DR, Berman KF.

Arch Gen Psychiatry. 2012 Aug;69(8):804-13. doi: 10.1001/archgenpsychiatry.2011.1893.

PMID:
22868934
43.

The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.

Goker-Alpan O, Masdeu JC, Kohn PD, Ianni A, Lopez G, Groden C, Chapman MC, Cropp B, Eisenberg DP, Maniwang ED, Davis J, Wiggs E, Sidransky E, Berman KF.

Brain. 2012 Aug;135(Pt 8):2440-8. doi: 10.1093/brain/aws174.

44.

The neurobiology of Alzheimer disease defined by neuroimaging.

Masdeu JC, Kreisl WC, Berman KF.

Curr Opin Neurol. 2012 Aug;25(4):410-20. doi: 10.1097/WCO.0b013e3283557b36. Review.

PMID:
22766722
45.

Imaging brain networks and brain diseases.

Masdeu JC.

Curr Opin Neurol. 2012 Aug;25(4):373-4. doi: 10.1097/WCO.0b013e328355a300. No abstract available.

PMID:
22710360
46.

Midbrain presynaptic dopamine tone predicts sustained and transient neural response to emotional salience in humans: fMRI, MEG and FDOPA PET.

Jabbi M, Nash T, Kohn P, Ianni A, Rubinstein D, Holroyd T, Carver FW, Masdeu JC, Kippenhan JS, Robinson SE, Coppola R, Berman KF.

Mol Psychiatry. 2013 Jan;18(1):4-6. doi: 10.1038/mp.2012.12. Epub 2012 Mar 13. No abstract available.

47.

Isolated and prolonged loss of time orientation.

Masdeu JC.

Neurology. 2011 Sep 13;77(11):1104-5; authore reply 1105. doi: 10.1212/WNL.0b013e3182294151. No abstract available.

PMID:
21911737
48.

Neuroimaging in psychiatric disorders.

Masdeu JC.

Neurotherapeutics. 2011 Jan;8(1):93-102. doi: 10.1007/s13311-010-0006-0. Review.

49.

Brain glucose metabolism in vascular white matter disease with dementia: differentiation from Alzheimer disease.

Pascual B, Prieto E, Arbizu J, Marti-Climent J, Olier J, Masdeu JC.

Stroke. 2010 Dec;41(12):2889-93. doi: 10.1161/STROKEAHA.110.591552. Epub 2010 Nov 4.

PMID:
21051671
50.

Seasonal effects on human striatal presynaptic dopamine synthesis.

Eisenberg DP, Kohn PD, Baller EB, Bronstein JA, Masdeu JC, Berman KF.

J Neurosci. 2010 Nov 3;30(44):14691-4. doi: 10.1523/JNEUROSCI.1953-10.2010.

Supplemental Content

Loading ...
Support Center